Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-04

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals Inc.'s supplemental application for Donepezil hydrochloride, a generic product, expanding availability for treating Alzheim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)